Cybin to present at public ventures discovery day on march 19th in dallas

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced participation in the upcoming public ventures discovery day on march 19, 2024 in dallas, tx. doug drysdale, chief executive officer of cybin will participate in a fireside chat at the event and will be avai.
CYBN Ratings Summary
CYBN Quant Ranking